MCKMcKesson Corporation
AI adoption · Q1 2026 earnings call
Health CareScaling
7
extracted from this call
4 / 5
quantified with specifics
Not disclosed
no breakout in this call
McKesson discussed AI primarily as an internal productivity and operational efficiency tool across three distinct use cases: Ambient Scribe technology deployed to over 1,900 oncology providers, an AI-powered advanced storage and retrieval system in its new Montreal distribution center, and AI-driven inventory planning capabilities embedded in its supply chain. Management framed AI as a contributor to operating efficiency and working capital savings but provided no explicit financial quantification of AI's revenue or profit contribution. Commentary was operational in nature with specific deployment metrics for Ambient Scribe.
Adopter
See full leaderboard →66/ 100
78
stage: scaling · max spec: 4
55
3 quant outcomes
65
2 scopes
internal_useinfrastructure_build
7 AI mentions from this call.
Extracted verbatim from the MCK Q1 2026 earnings call transcript. Speaker, section, and specificity tier surfaced for each mention.
- T4Prepared remarks· CEO· Internal use
“Across our supply chains, AI-driven inventory planning capabilities are helping us move from reactive to more technology-enabled real-time decision-making. We implemented an advanced planning system that uses AI to connect and orchestrate end-to-end planning across demand, supply, inventory and operations inside an integrated environment. This transformation enables us to deliver working capital savings and meaningfully contributed to the strong operating cash flow in fiscal 2026.”
— Brian Tyler, MCK earnings call - T4Prepared remarks· CEO· Internal use
“As we scale the platform, we're embedding automation and AI to improve workflow and enhance the patient experience. Within the U.S. Oncology Network, Ambient Scribe technology is now used by more than 1,900 providers. This allows them to spend more time with patients and less time on documentation, allowing them to do the jobs they trained for.”
— Brian Tyler, MCK earnings callAmbient Scribe - T3Q&A· CEO· Internal usehow is the pipeline changing in terms of additional services you can build out as you get bigger and scaled?
“part of that expansion rest on the strong value proposition we have for providers, including the investments we're making in the practices themselves in things like Ambient Scribe, making the physician work experience, just focus more on patient care, less on administrative burden that we think that helps address burnout, that attracts people to our network”
— Brian Tyler, MCK earnings callAmbient Scribe - T3Prepared remarks· CFO· Internal use
“We achieved this operating efficiency while simultaneously making targeted investments to modernize our operations through automation and AI-driven capabilities, which we anticipate will accelerate growth, creating enterprise-wide efficiencies.”
— Britt Vitalone, MCK earnings call - T3Prepared remarks· CEO· Infrastructure build
“this state-of-the-art facility expands critical capacity and features industry-leading automation, including an advanced storage and retrieval system powered by AI and robots, which raised the standard for precision and performance.”
— Brian Tyler, MCK earnings call - T2Q&A· CEO· Internal usehow is the pipeline changing in terms of additional services you can build out as you get bigger and scaled? And where are the opportunities to continue to expand, whether it's within oncology or other areas, the totality of services to potentially drive incremental revenue and profit streams?
“So I think as these technologies emerge and we continue to take better and better advantage of them, we'll continue to find ways to deepen both our value proposition for the physicians and for the manufacturers, and that creates sort of this virtuous cycle.”
— Brian Tyler, MCK earnings callAmbient Scribe - T2Prepared remarks· CEO· Internal use
“These capabilities illustrate how we're using data technology and scale to meaningfully improve our physicians' productivity and dedicate more time to care delivery.”
— Brian Tyler, MCK earnings callAmbient Scribe
What management wouldn’t quantify.
Analyst questions where management declined to share a specific number. The pattern of refusals is often as informative as the disclosures.
- No quantification of AI's direct contribution to revenue or operating profit despite multiple references to AI-driven efficiency gains.
- No disclosure of AI-specific capital expenditure or R&D spend; capex of $745M for FY2026 described only as 'distribution technology and infrastructure' without AI-specific breakdown.
- Ambient Scribe user count (1,900 providers) disclosed but no productivity metric (e.g., time saved per provider, documentation reduction %) or financial impact provided.
- AI-driven inventory planning described as contributing to 'working capital savings' and 'strong operating cash flow' but no dollar amount attributed to AI specifically.
- No disclosure of AI vendor, model provider, or technology partner for any of the named AI capabilities.
- Corporate expenses guidance of $580M-$640M references 'technology innovation and efficiency' investments but does not break out AI-specific spend.
Compare with peers.
Other companies in the same sector and at the same AI adoption stage.
Same GICS sector, all stages
Independent research, direct to your inbox.
Live data tracking and analysis. Deep research that cuts through consensus. Evidence-backed insights.